Meningococcal disease

Supportive measures include IV fluids, oxygen, inotropic support, e. Meningococcemia often involves hypotension, acute adrenal hemorrhage, and multiorgan failure.

The importance of the carrier state in meningococcal disease is well known. Travelers to or residents of areas where N. Twenty years ago in Massachusetts there were cases of Meningococcal disease disease per year.

But call your doctor right away if you have a strong reaction to the vaccine. Antibiotics are used to treat people with both meningococcal meningitis and meningococcemia. Meningitis A,C,Y and W vaccines rarely may be used as an adjunct to chemoprophylaxis,1 but only in situations where there is an ongoing risk of exposure e.

Meningococcal Disease

How is meningococcal disease diagnosed? Meningococcal polysaccharide vaccine MPSV4 -- This vaccine was approved in the s and protects Meningococcal disease most forms of meningococcal disease. You may improve this articlediscuss the issue on the talk pageor create a new articleas appropriate.

They confer longer-lasting immunity 5 years and moreprevent carriage and induce herd immunity. Neisseria meningitidis only infects humans; there is no animal reservoir. Adolescents and young adults aged 16—23 years may also be vaccinated with a serogroup B meningococcal MenB vaccine to provide short-term protection against most strains of serogroup B meningococcal disease.

Babies with meningitis will usually have a fever, but this is not a reliable sign of illness. The most critical diagnostics needed for meningitis outbreak control are being Meningococcal disease in the use cases document.

However, with the introduction of a monovalent serogroup A meningococcal conjugate vaccine [MenAfriVac] in the region starting inrecent meningococcal outbreaks have primarily been due to serogroups C and W, although serogroup X outbreaks are also reported.

Meningitis A,C,Y and W vaccines rarely may be used as an adjunct to chemoprophylaxis,1 but only in situations where there is an ongoing risk of exposure e. Meningococcal meningitis, caused by Neisseria meningitidis bacteria, is of particular importance due to its potential to cause large epidemics.

How common is meningococcal disease? Twelve types of N. They can be used as soon as of one year of age. Over time, there have been major improvements in strain coverage and vaccine availability, but to date no universal vaccine against meningococcal disease exists. However, the carriage rate may be higher in epidemic situations.

At the current time, there is no routine recommendation and no statewide requirement for meningococcal B vaccination before going to college although some colleges might decide to have such a requirement.

Meningococcal disease

Serogroup specific vaccines are used for prevention routine immunization and in response to outbreaks prompt reactive vaccination.

Benzylpenicillin and chloramphenicol are also effective. Meningococcal meningitis is characterized by sudden onset of headache, fever, and stiffness of the neck, sometimes accompanied by nausea, vomiting, photophobia, or altered mental status. Hospital Infection Control Practices Advisory Committee HICPAC recommendations regarding immunization of health-care workers that routine vaccination of health-care personnel is recommended, Any individual 11—55 years of age who wishes to reduce their risk of meningococcal disease may receive meningitis A,C,Y and W vaccines and those older than 55 years of age.

Anyone who has these symptoms should be seen by a health care provider right away. These policies may change as new information becomes available. Estimate the impact of meningitis control strategies, particularly preventive vaccination programs. What is the treatment of meningococcal disease?

A second dose of quadrivalent meningococcal conjugate vaccine is routinely recommended at 16 years of age. They are not effective before 2 years of age. Usually, the bacteria go away and these people may have increased resistance to infection in the future.

Meningococcal meningitis

Although the KSA Ministry of Health currently advises against travel to Hajj for pregnant women or children, these groups should receive meningococcal vaccination according to licensed indications for their age if they travel.

There are 12 serogroups of N. The meningococcal vaccine can prevent meningitis infection. Because the meningococcal organism is transmitted by respiratory droplets and is susceptible to drying, it has been postulated that close contact is necessary for transmission.

It is recommended for all children years of age and for some younger children with certain health conditions like asplenia including sickle cell diseaseor prior to travel to certain parts of the world where meningococcal disease is common. Secondary school those schools with grade What should I do if I have had close contact with a person who has meningococcal disease?

Current visa requirements should be confirmed with the KSA embassy. Meningococcal meningitis and meningococcemia.Meningococcal meningitis is a serious disease -- even with treatment. That's why prevention is a far better approach.

The meningococcal vaccine can. Meningococcal meningitis is observed worldwide but the highest burden of the disease is in the meningitis belt of sub-Saharan Africa, stretching from Senegal in the west to Ethiopia in the east.

Around 30 cases are still reported each year from that area. Meningococcal disease can refer to any illness caused by the type of bacteria called Neisseria meningitidis, also known as meningococcus [muh-ning-goh-KOK-us]. These illnesses are often severe and can be deadly.

Meningococcal meningitis is a serious disease -- even with treatment. That's why prevention is a far better approach. The meningococcal vaccine can prevent meningitis infection. Meningococcal disease is rare, but people do get it — and teens, young adults, and people with certain health conditions are at increased risk.

Meningococcal Disease

Meningococcal disease can cause serious infections of the lining of the brain and spinal cord or the blood. CLINICAL PRESENTATION. Meningococcal disease generally occurs 1–10 days after exposure and presents as meningitis in ≥50% of cases.

Meningococcal meningitis is characterized by sudden onset of headache, fever, and stiffness of the neck, sometimes accompanied by nausea, vomiting, photophobia, or altered mental status.

Download
Meningococcal disease
Rated 5/5 based on 65 review